Inadvertently Disclosed Data Ordered Returned In Incretin Mimetic MDL
SAN DIEGO — The California federal judge overseeing the incretin mimetic multidistrict litigation on Sept. 11 ordered the return of inadvertently disclosed data from defendant Novo Nordisk Inc.’s LEADER clinical trial,...To view the full article, register now.
Already a subscriber? Click here to view full article